Michael Samarinas

486 total citations
34 papers, 320 citations indexed

About

Michael Samarinas is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Michael Samarinas has authored 34 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Urology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Rheumatology. Recurrent topics in Michael Samarinas's work include Urinary Bladder and Prostate Research (18 papers), Pelvic floor disorders treatments (13 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Michael Samarinas is often cited by papers focused on Urinary Bladder and Prostate Research (18 papers), Pelvic floor disorders treatments (13 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). Michael Samarinas collaborates with scholars based in Greece, United Kingdom and United States. Michael Samarinas's co-authors include Konstantinos Skriapas, Elpiniki I. Papageorgiou, Anastasios Karatzas, Wojciech Froelich, Michael D. Melekos, Stavros Gravas, Ioannis Zachos, Charalampos Konstantinidis, Theodore Anagnostou and Alexandre de la Taille and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Applied Soft Computing.

In The Last Decade

Michael Samarinas

29 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Samarinas Greece 11 120 96 64 51 46 34 320
Yılmaz Aksoy Türkiye 11 101 0.8× 93 1.0× 23 0.4× 87 1.7× 23 0.5× 24 314
Rupa Patel United States 8 128 1.1× 139 1.4× 17 0.3× 77 1.5× 86 1.9× 19 307
Oğuz Özden Cebeci Türkiye 7 118 1.0× 75 0.8× 59 0.9× 54 1.1× 47 1.0× 16 227
Manabu Ichino Japan 11 102 0.8× 44 0.5× 7 0.1× 103 2.0× 23 0.5× 35 332
Yuki Endo Japan 10 57 0.5× 15 0.2× 20 0.3× 99 1.9× 29 0.6× 56 456
Frederik Wessels Germany 10 117 1.0× 32 0.3× 66 1.0× 108 2.1× 19 0.4× 40 332
Guolin Wu China 11 36 0.3× 17 0.2× 40 0.6× 20 0.4× 26 0.6× 33 349
Tuan Dinh United States 11 105 0.9× 28 0.3× 35 0.5× 178 3.5× 6 0.1× 24 578
Yongwei Li China 13 63 0.5× 82 0.9× 7 0.1× 163 3.2× 26 0.6× 51 370
Manuel Neuberger Germany 9 111 0.9× 16 0.2× 45 0.7× 50 1.0× 22 0.5× 38 232

Countries citing papers authored by Michael Samarinas

Since Specialization
Citations

This map shows the geographic impact of Michael Samarinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Samarinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Samarinas more than expected).

Fields of papers citing papers by Michael Samarinas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Samarinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Samarinas. The network helps show where Michael Samarinas may publish in the future.

Co-authorship network of co-authors of Michael Samarinas

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Samarinas. A scholar is included among the top collaborators of Michael Samarinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Samarinas. Michael Samarinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pontari, Michel A., et al.. (2025). Interstitial Cystitis/Bladder Pain Syndrome in Men. Neurourology and Urodynamics. 45(1). 26–31.
3.
Samarinas, Michael, Wendy Bower, Roger R. Dmochowski, et al.. (2024). Optimizing care for LUTS in older patients: Diagnostics, challenges of frailty and patient priorities—NOPIA meeting (ICI-RS 2024). SHILAP Revista de lepidopterología. 13. 101737–101737.
4.
Gravas, Stavros, Cosimo De Nunzio, Luís Campos Pinheiro, et al.. (2024). Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms. Prostate Cancer and Prostatic Diseases. 28(2). 405–410. 2 indexed citations
5.
Hajebrahimi, Sakineh, Charalampos Konstantinidis, Michael Samarinas, et al.. (2024). Safety and Efficacy of Trospium Chloride and Solifenacin in Stroke‐Induced Neurogenic Lower Urinary Tract Dysfunction: A Randomized Controlled Trial. Neurourology and Urodynamics. 44(1). 85–95.
7.
Hanno, Philip M., Mauro Cervigni, J. Quentin Clemens, et al.. (2023). Summary of the 2023 report of the international consultation on incontinence interstitial cystitis/bladder pain syndrome (IC/BPS) committee. SHILAP Revista de lepidopterología. 8. 101056–101056. 8 indexed citations
8.
Sakalis, Vasileios, et al.. (2023). The effect of pelvic floor muscle training in women with functional bladder outlet obstruction. Archives of Gynecology and Obstetrics. 307(5). 1489–1494. 5 indexed citations
10.
Mykoniatis, Ioannis, et al.. (2022). Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis. Biologics. Volume 16. 47–55. 7 indexed citations
11.
Koinis, Filippos, et al.. (2022). Emerging Role of YAP and the Hippo Pathway in Prostate Cancer. Biomedicines. 10(11). 2834–2834. 8 indexed citations
12.
Samarinas, Michael, et al.. (2020). The Clinical Impact of Hexanic Extract of Serenoa repens in Men with Prostatic Inflammation: A Post Hoc Analysis of a Randomized Biopsy Study. Journal of Clinical Medicine. 9(4). 957–957. 2 indexed citations
13.
Holeva, Vasiliki, et al.. (2019). Health Behaviours, Quality of Life and Treatment Adherence in neurogenic versus non-neurogenic Urinary Incontinence. Neurourology and Urodynamics. 1 indexed citations
14.
Gravas, Stavros, et al.. (2018). The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study. World Journal of Urology. 37(3). 539–544. 25 indexed citations
15.
Samarinas, Michael, Mauro Gacci, Alexandre de la Taille, & Stavros Gravas. (2018). Prostatic inflammation: a potential treatment target for male LUTS due to benign prostatic obstruction. Prostate Cancer and Prostatic Diseases. 21(2). 161–167. 14 indexed citations
16.
Samarinas, Michael, et al.. (2017). Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications. HORMONES. 16(2). 115–123. 21 indexed citations
17.
Karatzas, Anastasios, Ioannis Zachos, Konstantinos Dimitropoulos, et al.. (2016). Generalized Lymphadenopathy of Prostate Adenocarcinoma Origin. A Case Series. Urology. 91. e3–e4. 1 indexed citations
19.
Anagnostou, Theodore, et al.. (2013). Two-step Minipercutaneous Ureterolithotripsy Under Multimodal Analgesia for Complicated Impacted Calculi in Proximal Ureter. Urology. 81(6). 1147–1153. 4 indexed citations
20.
Zachos, Ioannis, Michael Samarinas, Anastasios Karatzas, et al.. (2013). Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG. Tumor Biology. 35(5). 4185–4189. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026